血Apo-E介导的皮质脊柱管异常和严重抑郁症患者的自杀倾向
Xiaoxia Lei1, Xinyu Fang1, Juanjuan Ren1
1Shanghai Jiao Tong University School of Medicine, Shanghai, China.
European archives of psychiatry and clinical neuroscience
|January 24, 2024
概括
脂蛋白E (Apo-E) 水平可能会调解大脑白质变化与重大抑郁症 (MDD) 中自杀风险之间的联系. 下方的Apo-E和皮质脊髓中改变的白质与增加的自杀倾向有关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 遗传学 是一个遗传学.
背景情况:
- 大型抑郁症 (MDD) 是全球导致残疾的主要原因.
- 在MDD中,自杀是一种复杂的现象,神经生物学基础不明.
- 脂蛋白E (Apo-E) 涉及各种神经过程,但其在MDD自杀性中的作用尚不清楚.
研究的目的:
- 调查血Apo-E水平,大脑白质完整性和MDD患者的自杀倾向之间的关联.
- 探索潜在的神经免疫机制,将Apo-E与MDD中自杀风险联系起来.
- 为了区分MDD患者与没有自杀倾向之间的神经成像和生化标志物.
主要方法:
- 扩散张力成像 (DTI) 和基于通道的空间统计 (TBSS) 用于评估白质微观结构.
- 血Apo-E水平测量在患有MDD的患者和健康对照组中.
- 差异分析 (ANOVA) 和中介分析用于检查群体差异和变量之间的关系.
主要成果:
- 与没有自杀倾向的患者相比,患有MDD和自杀倾向的患者的血Apo-E水平较低.
- 没有自杀的MDD组在左侧皮质脊髓和左侧体中显示出平均扩散率的增加.
- 调解分析表明,左皮质脊柱管中增加的平均扩散率有助于自杀得分,Apo-E调解了这一效应.
结论:
- 脂蛋白E可能在皮质脊椎管中的白质变化与MDD中自杀风险之间的关系中发挥中介作用.
- 这些发现表明,潜在的神经免疫途径有助于重大抑郁症中自杀倾向.
- 需要进一步的研究来阐明涉及Apo-E在MDD自杀倾向中的精确神经免疫机制.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
Depression: Overview
244
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
244
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Mania and Antimanic Drugs: Overview
181
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K


